Yoori Lee serves as Executive at AIT Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Yoori Lee has executed 5 insider transactions totaling $44.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 28, 2023 involved purchasing 3,115 shares valued at $19.7K.
Yoori Lee currently holds 12,654 shares of AIT Therapeutics, Inc. (AITB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yoori Lee has been a net buyer of AITB stock. They have purchased $44.8K and sold $0 worth of shares.
Yoori Lee's most recent insider trade was on Mar 28, 2023, when they purchased 3,115 shares at $6.34 per share.
Get notified when new Form 4 filings are submitted
| $4.25 |
| Discretionary |
| Jan 21, 2021 | XAIR | $10.0K | Option Exercise | 2,342 | $4.25 | Discretionary |
| Jun 3, 2019 | XAIR | $25.0K | Purchase | 4,855 | $5.15 | Discretionary |
| Feb 16, 2018 | AITB | $10.0K | Option Exercise | 2,342 | $4.25 | Discretionary |